```
Response to TNF antagonist treatment
Anti-cyclic Citrullinated Peptide Antibody
Response to tocilizumab in rheumatoid arthritis
Response to TNF-alpha inhibitors in rheumatoid arthritis
Response to anti-TNF therapy in rheumatoid arthritis
Response to methotrexate in rheumatoid arthritis
Rheumatoid arthritis (ACPA-negative)
Joint damage progression in ACPA-negative rheumatoid arthritis
Response to anti-TNF therapy in rheumatoid arthritis
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
Rheumatic heart disease
Bone erosion in rheumatoid arthritis
Severe progression in rheumatoid arthritis
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
Sero-negative rheumatoid arthritis
ACPA-positive rheumatoid arthritis (smoking interaction)
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
```
